Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 6Completed 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 20Recurrence 5Leukemia, Myeloid, Acute 4Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Waldenstrom Macroglobulinemia 1Renal Insufficiency 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin Light-chain Amyloidosis 1Hypergammaglobulinemia 1Hodgkin Disease 1Hematologic Diseases 1Disease 1Breast Neoplasms 1

Interventions

Melphalan 5Filgrastim 4birtamimab 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3pomalidomide 2Calcium Dobesilate 2Bortezomib 2venetoclax 1pegfilgrastim 1nelarabine 1melflufen 1daratumumab 1Tetradecanoylphorbol Acetate 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Moxifloxacin 1Morphine 1Methadone 1Fluorescent Antibody Technique 1Fentanyl 1Diuretics 1Ciprofloxacin 1Blood Component Removal 1Amoxicillin-Potassium Clavulanate Combination 1Amifostine 14'-deoxy-4'-iododoxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immunoglobulin Light-chain Amyloidosis × daratumumab × Clear all
NCT04895917 2025-02-20

DarPAL

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 2 Terminated
27 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡